8-K
filed November 13, 2023, 6:59 PM ET
ticker AEMD
CIK 0000882291
leadership
confidence high
sentiment neutral
materiality 0.65
Aethlon Medical appoints James B. Frakes as Interim CEO; Charles J. Fisher Jr. departs
AETHLON MEDICAL INC
- Charles J. Fisher Jr., M.D. departed as CEO effective Nov 7, 2023; Guy F. Cipriani resigned as director.
- James B. Frakes appointed as Interim CEO and Board member, retains CFO role.
- Guy F. Cipriani appointed as Senior VP and COO; resigned from Board.
- Frakes' base salary $360,000 (set Jan 2023); eligible for discretionary bonus.
- Company plans amended employment agreements for Frakes and Cipriani.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Charles J. Fisher, Jr., M.D. departed as Chief Executive Officer at AETHLON MEDICAL INC.
- Action
- departed
- Role
- Chief Executive Officer
Exact text from the filing
(b) Departure of Charles J. Fisher, Jr., M.D. as Chief Executive Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Guy F. Cipriani was appointed as Senior Vice President and Chief Operating Officer at AETHLON MEDICAL INC.
- Action
- appointed
- Role
- Senior Vice President and Chief Operating Officer
Exact text from the filing
Guy F. Cipriani, formerly Senior Vice President and Chief Business Officer of the Company, (i) was appointed as the Company’s Senior Vice President and Chief Operating Officer and (ii) resigned from the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
James B. Frakes was appointed as Director at AETHLON MEDICAL INC.
- Action
- appointed
- Role
- Director
Exact text from the filing
Effective November 7, 2023, James B. Frakes, Chief Financial Officer of Aethlon Medical, Inc. (the “Company”), was appointed as (i) Interim Chief Executive Officer of the Company, replacing Charles J. Fisher, Jr. M.D., and (ii) a member of the Board of Directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
James B. Frakes was appointed as Interim Chief Executive Officer at AETHLON MEDICAL INC.
- Action
- appointed
- Role
- Interim Chief Executive Officer
Exact text from the filing
Effective November 7, 2023, James B. Frakes, Chief Financial Officer of Aethlon Medical, Inc. (the “Company”), was appointed as (i) Interim Chief Executive Officer of the Company, replacing Charles J. Fisher, Jr. M.D., and (ii) a member of the Board of Directors of the Company (the “Board”).
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Guy F. Cipriani resigned as Director at AETHLON MEDICAL INC.
- Action
- resigned
- Role
- Director
Exact text from the filing
Guy F. Cipriani, formerly Senior Vice President and Chief Business Officer of the Company, (i) was appointed as the Company’s Senior Vice President and Chief Operating Officer and (ii) resigned from the Board.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.